Lurasidone Hydrochloride Patent Expiration
Lurasidone Hydrochloride is used for treating bipolar depression, major depressive episodes, and schizophrenia with improvement in attention function, negative symptoms, and cognitive dysfunction. It was first introduced by Sunovion Pharmaceuticals Inc
Lurasidone Hydrochloride Patents
Given below is the list of patents protecting Lurasidone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Latuda |
US9259423 (Pediatric) | Method of treatment for mental disorders | Nov 23, 2031 | Sunovion Pharms Inc |
| Latuda | US9259423 | Method of treatment for mental disorders | May 23, 2031 | Sunovion Pharms Inc |
| Latuda | US9827242 | Method of treatment for mental disorders | May 23, 2031 | Sunovion Pharms Inc |
| Latuda |
US8729085 (Pediatric) | Pharmaceutical composition | Nov 26, 2026 | Sunovion Pharms Inc |
| Latuda |
US8883794 (Pediatric) | Pharmaceutical composition | Nov 26, 2026 | Sunovion Pharms Inc |
| Latuda |
US9907794 (Pediatric) | Pharmaceutical composition | Nov 26, 2026 | Sunovion Pharms Inc |
| Latuda | US8729085 | Pharmaceutical composition | May 26, 2026 | Sunovion Pharms Inc |
| Latuda | US8883794 | Pharmaceutical composition | May 26, 2026 | Sunovion Pharms Inc |
| Latuda | US9555027 | Pharmaceutical composition | May 26, 2026 | Sunovion Pharms Inc |
| Latuda | US9907794 | Pharmaceutical composition | May 26, 2026 | Sunovion Pharms Inc |
| Latuda |
USRE45573 (Pediatric) | Process for producing imide compound | Dec 23, 2025 | Sunovion Pharms Inc |
| Latuda | USRE45573 | Process for producing imide compound |
Jun 23, 2025
(Expired) | Sunovion Pharms Inc |
| Latuda |
US9174975 (Pediatric) | Remedy for integration dysfunction syndrome |
Aug 20, 2024
(Expired) | Sunovion Pharms Inc |
| Latuda | US9174975 | Remedy for integration dysfunction syndrome |
Feb 20, 2024
(Expired) | Sunovion Pharms Inc |
| Latuda | US9815827 | Agent for treatment of schizophrenia |
Feb 20, 2024
(Expired) | Sunovion Pharms Inc |
| Latuda |
US5532372 (Pediatric) | Imide derivatives, and their production and use |
Jan 02, 2019
(Expired) | Sunovion Pharms Inc |
| Latuda | US5532372 | Imide derivatives, and their production and use |
Jul 02, 2018
(Expired) | Sunovion Pharms Inc |
| Latuda | US5532372 | Imide derivatives, and their production and use |
Jul 02, 2018
(Expired) | Sunovion Pharms Inc |
Lurasidone Hydrochloride's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List